Alterations of SCFA levels in neuroinflammatory disorders
Pathology | SCFA | Effect | Reference |
---|---|---|---|
MS | ↓ Propionate in stool and serum | Reduced Treg number, metabolism, and function. Increased Th17 number. | [14, 19] |
↓ Propionate in faeces and acetate in plasma | Reduced SCFA promotes an inflammatory phenotype in gut mucosal T cells. | [9, 15] | |
AD | ↓ Butyrate | AD patients with brain amyloid accumulation and endothelial dysfunction had decreased blood butyrate. | [20, 21] |
↓ Butyrate | In faeces and brain of APP/PS1 AD mice model. Butyrate can hinder the oligomerization of amyloid-β 1-40. | [22, 23] | |
PD | ↓ SCFA in faeces | Significant decline of butyrate, acetate, and propionate in faecal of PD individuals compared to controls. | [18, 24] |
↓ Acetate ↑ Butyrate and propionate in faeces | Microbiota-derived SCFA regulates motor deficits and neuroinflammation in mouse models. | [17] |